Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Cardlytics's Sloan Ratio for the quarter that ended in Dec. 2023 was -18.29%.
As of Dec. 2023, Cardlytics has a Sloan Ratio of -18.29%, indicating there is a warning stage of accrual build up.
Cardlytics Sloan Ratio % Historical Data
The historical data trend for Cardlytics's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cardlytics's Sloan Ratio %
For the Advertising Agencies subindustry, Cardlytics's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardlytics's Sloan Ratio % Distribution in the Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Cardlytics's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Cardlytics's Sloan Ratio % falls into.
Cardlytics Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Cardlytics's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as
Cardlytics's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 33.038 (Mar. 2023 ) + -23.508 (Jun. 2023 ) + -23.966 (Sep. 2023 ) + -100.836 (Dec. 2023 ) = $-115.3 Mil.
Cardlytics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -10.064 (Mar. 2023 ) + 5.751 (Jun. 2023 ) + 1.194 (Sep. 2023 ) + 2.934 (Dec. 2023 ) = $-0.2 Mil.
Cardlytics's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -2.802 (Mar. 2023 ) + -2.747 (Jun. 2023 ) + -3.146 (Sep. 2023 ) + -1.367 (Dec. 2023 ) = $-10.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardlytics (NAS:CDLX) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2023, Cardlytics has a Sloan Ratio of -18.29%, indicating there is a warning stage of accrual build up.
Cardlytics Sloan Ratio % Related Terms
Thank you for viewing the detailed overview of Cardlytics's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through three segments, Cardlytics Direct U.S. and U.K., and the Bridg platform. The Cardlytics Direct segment which generates the majority of revenue operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CDLX has been successfully added to your 